OBBI Showcases EV and Organoid Platforms at SFNano 2025
We are proud to join SFNano 2025 to showcase our cutting-edge services in organoid and extracellular vesicle (EV) bioproduction.
As a France 2030-labeled integrator, OBBI bridges academic excellence and industrial needs to accelerate innovation in nanomedicine and biotherapies.